MedPath

北京市燕京药业有限公司

Ownership
-
Established
1989-09-01
Employees
-
Market Cap
-
Website
www.yjyaoye.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

123

NMPA:123

Drug Approvals

Ethambutol Hydrochloride

Product Name
盐酸乙胺丁醇
Approval Number
国药准字H20093080
Approval Date
Jul 22, 2024
NMPA

Calcium Acetate

Product Name
醋酸钙
Approval Number
国药准字H20133221
Approval Date
Mar 23, 2023
NMPA

Ribavirin Injection

Product Name
利巴韦林注射液
Approval Number
国药准字H20043755
Approval Date
Dec 5, 2022
NMPA

Nitroglycerin Injection

Product Name
硝酸甘油注射液
Approval Number
国药准字H20073990
Approval Date
Sep 22, 2022
NMPA

Boric Acid

Product Name
硼酸
Approval Number
国药准字H11020496
Approval Date
Jul 19, 2022
NMPA

Nikethamide

Product Name
尼可刹米
Approval Number
国药准字H11020494
Approval Date
Jul 19, 2022
NMPA

Sodium Acetate

Product Name
醋酸钠
Approval Number
国药准字H11021960
Approval Date
Jul 19, 2022
NMPA

Nifedipine

Product Name
硝苯地平
Approval Number
国药准字H11020499
Approval Date
Jul 19, 2022
NMPA

Magnesium Sulfate

Product Name
硫酸镁
Approval Number
国药准字H11020489
Approval Date
Jul 19, 2022
NMPA

Hydroxycarbamide

Product Name
羟基脲
Approval Number
国药准字H11020505
Approval Date
Jul 19, 2022
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 13
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.